Should all acutely ill medical patients be treated with antithrombotic drugs? A review of the interventional trials

  • F. V
  • L. P
  • L. L
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

After reports from observational studies suggesting an association between acutely ill medical patients and venous thromboembolism (VTE), interventional trials with anticoagulants drugs have demonstrated a significant reduction of VTE during and immediately after hospitalisation. Although several guidelines suggest the clinical relevance of reducing this outcome, there is a low tendency to use anticoagulants in patients hospitalised for acute medical illness. We speculated that such underuse may be dependent on a low perception that patients included in the trials are actually at risk of thromboembolism. Therefore, the aim of this study was to analyse the clinical settings included in the interventional trials and their relationship with thrombotic risk. Analysis of interventional trials revealed that the majority of patients included in the trials (about 80%) were affected by heart failure, acute respiratory syndrome or infections. Among these three illnesses, literature data shows an association with venous thrombosis only in patients with acute infections; this finding was, however, supported only by retrospective study. On the contrary, there is scarce or no evidence that heart failure and acute respiratory syndrome are associated with venous thrombosis. These data underscore the need of better defining the thrombotic risk profile of acutely ill medical patients included in interventional trials with anticoagulants. © Schattauer 2013.

Author-supplied keywords

  • *anticoagulant agent/ct [Clinical Trial]
  • *venous thromboembolism
  • autopsy
  • computer assisted tomography
  • dalteparin
  • death
  • echography
  • enoxaparin
  • fondaparinux/cm [Drug Comparison]
  • fondaparinux/ct [Clinical Trial]
  • heart failure
  • human
  • low molecular weight heparin/cm [Drug Comparison]
  • low molecular weight heparin/ct [Clinical Trial]
  • lung angiography
  • lung embolism
  • lung scintiscanning
  • nadroparin
  • outcome assessment
  • phlebography
  • placebo
  • priority journal
  • randomized controlled trial (topic)
  • respiratory tract infection
  • review
  • risk
  • severe acute respiratory syndrome
  • systematic review

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Violi F.

  • Perri L.

  • Loffredo L.

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free